Ethos Technologies Inc. (LIFE), a digital health insurance platform, is trading at a 22% discount to its IPO price due to market worries about its growth sustainability and heavy reliance on three insurance partners that generate 88% of its 2025 revenue. The company posted strong 52% revenue growth and an 18% net margin in 2025 but expects growth to slow to 32% in 2026, citing rising client acquisition costs. Despite a conservative valuation at 12x P/E, well below peers in the insurtech sector, the stock could be undervalued if Ethos meets its 2026 EBITDA targets, diversifies its partner base, and maintains margins.
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
